|
Girish Nallur directs CTT's Intellectual Property Market Assessment and Valuation Services and is responsible for technical and market analyses of the technologies that CTT chooses for commercialization. Dr. Nallur brings to CTT over 20 years of scientific and project management experience in the biotechnology industry. He has over nine years experience in intellectual property due diligence including IP/Legal affairs technology assessments licensing and mergers and acquisitions.
Immediately prior to joining CTT Dr. Nallur was responsible for setting the intellectual property strategy and managing technology transfer and licensing for Molecular Staging Inc. based in New Haven Connecticut. Dr. Nallur has a Ph.D. in Molecular Biology from the Indian Institute of Science and has completed postdoctoral work at Scripps Research Institute the Wistar Institute and Yale University where he was also a full-time faculty member. | 